What is the primary purpose of this 8-K filing?

This 8-K filing announces a material definitive agreement, specifically the entry into an Agreement and Plan of Merger between Cardinal Health Inc. (CAH) and VIASYS Healthcare Inc. It details the terms of a tender offer and subsequent merger to acquire VIASYS.

What is the proposed offer price for VIASYS shares?

The proposed offer price is $42.75 per share of VIASYS common stock. Additionally, if the tender offer's acceptance for payment is delayed beyond 45 days from the merger agreement date, an additional $0.007027 per day will be added to the price for each day of delay.

What are the key conditions required for the tender offer to proceed?

Key conditions include the tender of a majority of VIASYS's outstanding shares on a fully diluted basis, the absence of injunctions, expiration of the Hart-Scott-Rodino antitrust waiting period, accuracy of VIASYS's representations and warranties, compliance with covenants, and the absence of a material adverse effect on VIASYS.

What is the 'Short-Form Merger Option' mentioned in the filing?

The Short-Form Merger Option grants Cardinal Health and its subsidiary the right to purchase additional VIASYS shares at the offer price, if needed, to ensure ownership of more than 90% of VIASYS's outstanding shares on a fully diluted basis, after acquiring at least 80% through the tender offer.

CAH 8-K: Material Agreements

Summary

Cardinal Health Inc. (CAH) has filed an 8-K report on May 13, 2007, detailing a significant material definitive agreement. The company, through its newly formed subsidiary Eagle Merger Corp., entered into an Agreement and Plan of Merger with VIASYS Healthcare Inc. This agreement outlines a cash tender offer by Merger Sub to acquire all outstanding shares of VIASYS common stock at $42.75 per share, with a potential daily increase if the offer's acceptance is delayed beyond 45 days. Following the tender offer, a merger is planned where Merger Sub will merge with and into VIASYS. The transaction is subject to customary closing conditions, including the tender of a majority of VIASYS's outstanding shares (fully diluted basis), regulatory approvals like the Hart-Scott-Rodino waiting period, and the absence of material adverse effects on VIASYS. This strategic move indicates Cardinal Health's intent to expand its operations through acquisition, the details of which are further elaborated in the filed merger agreement and a joint press release.

Key Highlights

1Cardinal Health Inc. (CAH) has entered into a Merger Agreement with VIASYS Healthcare Inc. through its subsidiary Eagle Merger Corp.
2The agreement initiates a cash tender offer to acquire all outstanding VIASYS common stock at $42.75 per share, plus a potential daily increase for delays beyond 45 days.
3A subsequent merger is planned where Merger Sub will merge with VIASYS, with remaining shares converted to the offer price.
4The tender offer requires a majority of VIASYS's outstanding shares (fully diluted basis) to be tendered.
5Customary conditions for the offer include antitrust approvals (Hart-Scott-Rodino), accuracy of representations, and absence of material adverse effects on VIASYS.
6VIASYS has granted Cardinal Health an irrevocable option to purchase additional shares to reach over 90% ownership, exercisable after acquiring 80%.
7A joint press release announcing the agreement was issued on May 14, 2007.

CARDINAL HEALTH INC 8-K Report, Material Agreement (May 14, 2007)

Summary

Key Highlights

Frequently Asked Questions